Eurobio Scientific SA (ALEHT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Eurobio Scientific SA (ALEHT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6615
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, which is used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. It develops other diagnostic products using its molecular biology platform such as Dx15, a molecular diagnostic test for thyroid cancer. Eurobio serves a range of therapeutic areas including infectious diseases, Alzheimer’s disease and cancer. The company commercializes in vitro diagnostic kits and instruments through its affiliate Ingen. It has presence in France and the US. Eurobio is headquartered in Paris, France.

Eurobio Scientific SA (ALEHT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eurobio Scientific SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Eurobio Scientific SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Eurobio Scientific SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Eurobio Scientific SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Eurobio Scientific SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Eurobio Scientific SA, Medical Equipment, Deal Details 10
Partnerships 10
Diaxonhit Enters Into Licensing And Distribution Agreement With CareDx (XDx) For AlloMap Molecular Expression Testing 10
Diaxonhit and Advanced Biological Labs Enter into Distribution Agreement 11
Ingen Expands Distribution Agreement with One Lambda 12
InGen BioSciences Enters Into Distribution Agreement With Quidel 13
InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 14
InGen BioSciences Enters Into Co-Marketing Agreement With Cylex For ImmuKnow Assays 15
Equity Offering 16
Diaxonhit to Raise USD9.5 Million in public offering of shares 16
Diaxonhit to Raise Funds through Private Placement of Shares 17
Exonhit Completes First Tranche Of Private Placement Of Shares For US$2 Million 18
Acquisition 19
Diaxonhit to Acquire GenBio for USD2 Million 19
Exonhit Completes Acquisition Of InGen BioSciences From Innoven Partenaires And Amundi Private Equity For US$23 Million 20
Eurobio Scientific SA – Key Competitors 22
Eurobio Scientific SA – Key Employees 23
Eurobio Scientific SA – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Jun 30, 2018: Eurobio Scientific announce 2018 mid year results 25
Other Significant Developments 26
Jul 23, 2018: Eurobio Scientific: 2018 mid-year activity report 26
Feb 15, 2018: Diaxonhit: Exclusive distribution of the VERIGENE molecular biology platform 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Eurobio Scientific SA, Medical Equipment, Key Facts, 2017 2
Eurobio Scientific SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Eurobio Scientific SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Eurobio Scientific SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Eurobio Scientific SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Eurobio Scientific SA, Deals By Market, 2012 to YTD 2018 8
Eurobio Scientific SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Diaxonhit Enters Into Licensing And Distribution Agreement With CareDx (XDx) For AlloMap Molecular Expression Testing 10
Diaxonhit and Advanced Biological Labs Enter into Distribution Agreement 11
Ingen Expands Distribution Agreement with One Lambda 12
InGen BioSciences Enters Into Distribution Agreement With Quidel 13
InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 14
InGen BioSciences Enters Into Co-Marketing Agreement With Cylex For ImmuKnow Assays 15
Diaxonhit to Raise USD9.5 Million in public offering of shares 16
Diaxonhit to Raise Funds through Private Placement of Shares 17
Exonhit Completes First Tranche Of Private Placement Of Shares For US$2 Million 18
Diaxonhit to Acquire GenBio for USD2 Million 19
Exonhit Completes Acquisition Of InGen BioSciences From Innoven Partenaires And Amundi Private Equity For US$23 Million 20
Eurobio Scientific SA, Key Competitors 22
Eurobio Scientific SA, Key Employees 23
Eurobio Scientific SA, Other Locations 24
Eurobio Scientific SA, Subsidiaries 24

List of Figures
Eurobio Scientific SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Eurobio Scientific SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Eurobio Scientific SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Eurobio Scientific SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Eurobio Scientific SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Eurobio Scientific SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Eurobio Scientific SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Eurobio Scientific SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Eurobio Scientific SA (ALEHT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NewYork-Presbyterian Hospital:企業の戦略的SWOT分析
    NewYork-Presbyterian Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Supernus Pharmaceuticals Inc (SUPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Supernus Pharmaceuticals Inc (Supernus) is a specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company's neurology portfolio consists of Oxtellar XR (oxcarbazepine), an adjunct therapy for the treatment …
  • Eiffage SA (FGR):電力:M&Aディール及び事業提携情報
    Summary Eiffage SA (Eiffage) is a construction and concession company. It operates in businesses of energy and infrastructure construction, real estate development, road construction, civil engineering, concessions, and public-private partnerships. The company’s activities include construction, reno …
  • Pacific World Corporation:企業の戦略・SWOT・財務情報
    Pacific World Corporation - Strategy, SWOT and Corporate Finance Report Summary Pacific World Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Mabuhay Vinyl Corp (MVC):企業の財務・戦略的SWOT分析
    Mabuhay Vinyl Corp (MVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Endeavour Mining Corporation:企業のM&A・事業提携・投資動向
    Endeavour Mining Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Endeavour Mining Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Georox Resources Inc (GXR):石油・ガス:M&Aディール及び事業提携情報
    Summary Georox Resources Inc (Georox Resources), formerly Oromonte Resources Inc is an oil and gas company that acquires, develops and explores petroleum and natural gas properties in Western Canada. The company's projects include Silverdale property, GP Channel project, Sparky Non Channel project, …
  • LEM Holding SA (LEHN):企業の財務・戦略的SWOT分析
    LEM Holding SA (LEHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SmartCool Systems Inc (SSC):企業の財務・戦略的SWOT分析
    Summary SmartCool Systems Inc (SmartCool Systems) is a clean technology company that manufactures and sells energy and cost reduction technologies. The company’s products include ECO3, ESM, and soft solutions. Its ECO3 and ESM are retrofit technologies that reduce the energy consumption of compresso …
  • scPharmaceuticals Inc (SCPH):製薬・医療:M&Aディール及び事業提携情報
    Summary ScPharmaceuticals Inc (scPharmaceuticals) is a clinical-stage pharmaceutical company. The company’s pipeline products include subcutaneous formulations of furosemide, ceftriaxone and carbapenem. Its furosemide formulation is a loop diuretic widely used in prescription pharmaceuticals for the …
  • AviChina Industry & Technology Co., Ltd.:企業の戦略・SWOT・財務情報
    AviChina Industry & Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary AviChina Industry & Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a biopharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases, and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • HTG Molecular Diagnostics Inc (HTGM):企業の財務・戦略的SWOT分析
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • Orvana Minerals Corporation:企業の戦略・SWOT・財務分析
    Orvana Minerals Corporation - Strategy, SWOT and Corporate Finance Report Summary Orvana Minerals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Citibank Berhad:企業の戦略的SWOT分析
    Citibank Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Quanta Services Inc (PWR):企業の財務・戦略的SWOT分析
    Quanta Services Inc (PWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • BBVA Banco Frances S.A.:企業の戦略・SWOT・財務情報
    BBVA Banco Frances S.A. - Strategy, SWOT and Corporate Finance Report Summary BBVA Banco Frances S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • QNB Finansbank (QNBFB):企業の財務・戦略的SWOT分析
    QNB Finansbank (QNBFB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Harvard University:企業のM&A・事業提携・投資動向
    Harvard University - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Harvard University Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the opera …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆